Xiaohong Rose Yang
#35,435
Most Influential Person Now
Biomedical scientist
Xiaohong Rose Yang's AcademicInfluence.com Rankings
Xiaohong Rose Yanglaw Degrees
Law
#2771
World Rank
#3443
Historical Rank
Common Law
#242
World Rank
#263
Historical Rank
Xiaohong Rose Yangbiology Degrees
Biology
#2679
World Rank
#4222
Historical Rank
Molecular Biology
#2771
World Rank
#2814
Historical Rank
Download Badge
Law Biology
Xiaohong Rose Yang's Degrees
- Bachelors Biomedical Sciences University of California, Berkeley
- PhD Biomedical Sciences Stanford University
Why Is Xiaohong Rose Yang Influential?
(Suggest an Edit or Addition)According to Wikipedia, Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Xiaohong Rose Yang's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Association analysis identifies 65 new breast cancer risk loci (2017) (922)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
- Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
- Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study (2007) (474)
- Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. (2020) (322)
- Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma (2014) (275)
- T (brachyury) gene duplication confers major susceptibility to familial chordoma (2009) (261)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
- Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in Taiwan (2005) (207)
- Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. (2011) (192)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
- Female breast cancer incidence among Asian and Western populations: more similar than expected. (2015) (137)
- Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants (2013) (121)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
- Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. (2016) (87)
- Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
- Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue (2014) (70)
- Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers. (2014) (69)
- Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. (2014) (69)
- Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics (2010) (67)
- Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population (2018) (63)
- Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. (2007) (60)
- Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions (2007) (60)
- CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. (2004) (59)
- BRCA1 and BRCA2 in breast cancer (1999) (57)
- Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance (2018) (56)
- DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations (2009) (56)
- Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: A population‐based analysis (2007) (55)
- Genomic regions linked to alcohol consumption in the Framingham Heart Study (2003) (54)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
- Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma (2014) (51)
- Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies (2010) (50)
- Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations (2013) (50)
- Breast cancer risk factors and mammographic density among high-risk women in urban China (2018) (48)
- Identification of modifier genes for cutaneous malignant melanoma in melanoma‐prone families with and without CDKN2A mutations (2009) (45)
- Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
- ERβ splice variant expression in four large cohorts of human breast cancer patient tumors (2014) (42)
- Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations (2010) (42)
- Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers (2012) (41)
- Immune gene expression profiling reveals heterogeneity in luminal breast tumors (2019) (40)
- Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma (2018) (39)
- Distribution of Epstein‐Barr viral load in serum of individuals from nasopharyngeal carcinoma high‐risk families in Taiwan (2006) (39)
- Occupational exposure to organic solvents and breast cancer in women (2009) (37)
- Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status (2014) (37)
- Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 (2017) (37)
- Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2020) (35)
- Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong. (2016) (34)
- Rare germline variants in known melanoma susceptibility genes in familial melanoma (2017) (32)
- Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. (2009) (32)
- Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival (2021) (31)
- Evaluation of certain food additives. Twenty-fourth Report of the Joint FAO/WHO Expert Committee on Food Additives. (1980) (30)
- Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis (2020) (29)
- Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women (2006) (27)
- Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland (2014) (27)
- A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (27)
- Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer (2013) (26)
- Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression (2019) (26)
- Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs) (2005) (26)
- Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations (2016) (23)
- Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma‐prone families with/without CDKN2A mutations (2012) (22)
- Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia (2017) (22)
- Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression (2013) (21)
- Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls (2018) (20)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
- Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data (2021) (20)
- Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. (2017) (18)
- On the Interplay of Telomeres, Nevi and the Risk of Melanoma (2012) (18)
- COMPENDIUM OF FOOD ADDITIVE SPECIFICATIONS, Joint FAO/WHO Expert Committee on Food Additives, 84th Meeting 2017 (2017) (18)
- The Val158Met polymorphism in the COMT gene is associated with increased cancer risks in Chinese population (2014) (17)
- Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT. (2019) (16)
- Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
- Construction and Validation of Tissue Microarrays of Ductal Carcinoma In Situ and Terminal Duct Lobular Units Associated With Invasive Breast Carcinoma (2006) (15)
- Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma‐prone family (2012) (15)
- A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
- Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium (2021) (14)
- Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades. (2018) (14)
- Variants Associated with Susceptibility to Pancreatic Cancer and Melanoma Do Not Reciprocally Affect Risk (2014) (14)
- Pediatric melanoma in melanoma‐prone families (2018) (14)
- Associations between mammographic density and tumor characteristics in Chinese women with breast cancer (2019) (13)
- Constitutional promoter methylation and risk of familial melanoma (2014) (13)
- Nighttime eating and breast cancer among Chinese women in Hong Kong (2017) (13)
- Characterization of Genomic Alterations in Radiation-Associated Breast Cancer among Childhood Cancer Survivors, Using Comparative Genomic Hybridization (CGH) Arrays (2015) (12)
- LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations (2013) (12)
- Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. (2016) (12)
- Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma. (2016) (12)
- Risk assessment model for invasive breast cancer in Hong Kong women (2016) (12)
- Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors (2017) (12)
- Variation in cutaneous patterns of melanomagenesis according to germline CDKN2A/CDK4 status in melanoma-prone families. (2020) (11)
- Mutation screening of CHD5 in melanoma-prone families linked to 1p36 revealed no deleterious coding or splice site changes (2008) (11)
- Greater absolute risk for all subtypes of breast cancer in the US than Malaysia (2014) (11)
- Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families (2013) (10)
- Constitutive mitochondrial DNA copy number in peripheral blood of melanoma families with and without CDKN2A mutations. (2014) (9)
- In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast Cancer (2020) (9)
- The impact of breast cancer‐specific birth cohort effects among younger and older Chinese populations (2016) (9)
- Linkage analysis of the GAW14 simulated dataset with microsatellite and single-nucleotide polymorphism markers in large pedigrees (2005) (9)
- Phenocopies in melanoma-prone families with germ-line CDKN2A mutations (2018) (8)
- Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya (2021) (7)
- Age-related DNA methylation in paired normal and tumour breast tissue in Chinese breast cancer patients (2020) (7)
- Emerging Concepts in Breast Cancer Risk Prediction (2013) (7)
- Identifying rheumatoid arthritis susceptibility genes using high-dimensional methods (2009) (7)
- FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients (2020) (7)
- Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers (2015) (7)
- Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
- Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2021) (6)
- Heterogeneous Associations Between Obesity and Reproductive-Related Factors and Specific Breast Cancer Subtypes Among Hong Kong Chinese Women (2020) (6)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
- Lack of inherited mutations of PTPRD in familial melanoma and melanoma‐astrocytoma syndrome (2009) (6)
- Familial Risks and Estrogen Receptor-Positive Breast Cancer in Hong Kong Chinese Women (2015) (6)
- PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies (2020) (6)
- Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer (2011) (5)
- The relationship between terminal duct lobular unit features and mammographic density among Chinese breast cancer patients (2019) (5)
- Metastasis in Breast Cancer Cells in Vivo Invasiveness and in Vitro Suppresses KAI 1 Overexpression of Updated Version (2001) (5)
- Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility (2020) (5)
- Distinct reproductive risk profiles for intrinsic-like breast cancer subtypes: pooled analysis of population-based studies. (2022) (5)
- Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility (2021) (4)
- Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN 2 A Mutations (2013) (4)
- Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain. (2020) (4)
- Disparities of time trends and birth cohort effects on invasive breast cancer incidence in Shanghai and Hong Kong pre- and post-menopausal women (2017) (4)
- Differential genomic landscape of clinically advanced/metastatic chordomas (mChor) based on primary tumor site. (2020) (3)
- Abstract 3414: Ethnic disparities in breast cancer survival in Sarawak, Malaysia (2016) (3)
- Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression (2019) (3)
- Divergent breast cancer incidence trends by hormone receptor status in the state of Sarawak, Malaysia (2019) (3)
- Comparison of somatic mutation landscapes in Chinese versus European breast cancer patients (2021) (3)
- Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program. (2020) (3)
- Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations (2021) (3)
- Linkage analysis of anti-CCP levels as dichotomized and quantitative traits using GAW15 single-nucleotide polymorphism scan of NARAC families (2007) (2)
- Abstract 3670: Systematic literature review of risk factor associations with breast cancer subtypes in women of African, Asian, Hispanic, and European descents (2022) (2)
- Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers (2012) (2)
- Re: Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians versus the US Population. (2020) (2)
- Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya (2021) (2)
- Peripheral blood immunologic phenotype of population‐based breast cancer cases and matched controls (2012) (2)
- Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer (2021) (2)
- Rare germline deleterious variants increase susceptibility for lung cancer. (2022) (2)
- VTET: a variable threshold exact test for identifying disease-associated copy number variations enriched in short genomic regions (2014) (2)
- The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of CDKN2A and CDK4 (2021) (2)
- Identification of susceptibility loci for complex diseases in a case-control association study using the Genetic Analysis Workshop 14 dataset (2005) (1)
- Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family (2021) (1)
- Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status (2014) (1)
- Abstract 2779: Relationship of mammographic density with breast cancer subtypes (2010) (1)
- Rare germline copy number variants (CNVs) and breast cancer risk (2022) (1)
- A comprehensive analysis of polymorphic variants in steroid hormone and insulin‐like growth factor‐1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium (2017) (1)
- Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium (2016) (1)
- Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis (2021) (1)
- Advances in Brief KAI 1 Protein Is Down-Regulated during the Progression of Human Breast Cancer 1 (2000) (1)
- Abstract 870: Analysis of breast cancer risk factors by expression of tumor markers: results of 34 studies in the Breast Cancer Association Consortium (BCAC) (2010) (1)
- Associations of Genetic Ancestry with Terminal Duct Lobular Unit Involution among Healthy Women. (2022) (1)
- A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (1)
- ASSOCIATION OF HUMAN LEUKOCYTE ANTIGENS (HLA) WITH NASOPHARYNGEAL CARCINOMA (NPC) IN HIGH-RISK MULTIPLEX FAMILIES IN TAIWAN (2009) (1)
- Abstract 1294: Prevalence and spectrum of germline rare variants inBRCA1/2andPALB2among breast cancer cases in Sarawak, Malaysia (2017) (1)
- Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma (2022) (1)
- Abstract P3-08-02: Common variants at 10p14 and 1p11.2 display heterogeneity in breast cancer associations by E-cadherin tumor tissue expression in two independent datasets (2012) (1)
- Abstract 2755: Germline copy number variations in melanoma families with/without CDKN2A/CDK4 mutations (2015) (1)
- Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (1)
- Abstract P1-09-12: TP53 expression in relation to clinical and etiologic factors in breast cancer subtypes (2019) (0)
- Abstract 2905: Clinical features in relation to age at diagnosis in luminal breast cancer patients: A hospital-based case series study in Beijing, China (2019) (0)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
- Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations (2016) (0)
- Additional file 2: Table S1. of Nighttime eating and breast cancer among Chinese women in Hong Kong (2017) (0)
- Abstract P5-08-20: Association between quantitative mammographic density and breast cancer subtypes among Chinese breast cancer patients (2020) (0)
- Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (0)
- Prognostic Significance of Tumor-infiltrating Lymphocytes in Premenopausal, Luminal Breast Cancer Treated with Adjuvant Endocrine Therapy (2020) (0)
- Comparative analysis between multimodalities for refractory locoregional recurrent breast cancer (2017) (0)
- Phenocopies in melanoma-prone families with germ-line CDKN2A mutations (2017) (0)
- Abstract LB-288: Differential cohort effect on early- and late-onset breast cancer incidence among Chinese women in different populations (2014) (0)
- Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
- Abstract 617: Aggressive phenotypes of luminal breast cancer demonstrate associations with body mass index analogous to triple-negative breast cancer (2019) (0)
- Abstract 1638: Whole-exome sequencing and protein interaction networks to prioritize candidate genes for cutaneous melanoma susceptibility (2019) (0)
- Abstract 5290: Racial variation in terminal duct lobular unit (TDLU) involution in Chinese and Polish breast cancer patients (2017) (0)
- Abstract 5570: Heterogeneity of luminal breast cancer characterized by immunohistochemical expression of basal markers (2015) (0)
- Association of germline variants in telomere maintenance genes (POT1, TERF2IP, ACD, and TERT) with spitzoid morphology in familial melanoma: A multi-center case series (2023) (0)
- Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry (2023) (0)
- FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. (2023) (0)
- Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) (0)
- Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population (2018) (0)
- Quantitative Mammographic Density Measurements and Molecular Subtypes in Chinese Women With Breast Cancer. (2020) (0)
- Disparities of time trends and birth cohort effects on invasive breast cancer incidence in Shanghai and Hong Kong pre- and post-menopausal women (2017) (0)
- Abstract LB-165: Identification of a luminal subtype with high immune abundance among breast cancer patients in Hong Kong, China (2018) (0)
- 126 Anatomic distribution of cutaneous melanoma in patients with and without germline CDKN2A and CDK4 mutations (2019) (0)
- Immune gene expression profiling reveals heterogeneity in luminal breast tumors (2019) (0)
- Breast cancer risk factors and mammographic density among high-risk women in urban China (2018) (0)
- Abstract P6-10-10: Association between mammographic density and breast cancer subtypes among Chinese women (2016) (0)
- Abstract PS13-17: Capecitabine maintaining treatment improves progression-free survival in metastatic breast cancer: A prospective observational study of 669 cases (2021) (0)
- Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family (2021) (0)
- Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma. (2021) (0)
- Abstract 688: Promoter methylation of death receptor decoy genes in blood and risk of melanoma in melanoma-prone families . (2013) (0)
- Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers. (2022) (0)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
- Integrated Analysis of Co-expression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma. (2022) (0)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
- Abstract C81: Differences in breast cancer incidence and survival patterns by tumor subtype and ethnicity in Sarawak, Malaysia (2014) (0)
- Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics. (2022) (0)
- Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls (2018) (0)
- Gene expression profiling identifies two chordoma subtypes associated with distinct molecular mechanisms and clinical outcomes. (2022) (0)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
- Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer. (2022) (0)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
- Abstract A81: Relationships between expression of TGF-β factors and breast tumor characteristics in a population-based study from Poland (2009) (0)
- Abstract 941: Exome sequencing identifiedPOT1, a telomere shelterin gene, as a major susceptibility gene for familial cutaneous malignant melanoma (2014) (0)
- The impact of coding germline variants on contralateral breast cancer risk and survival (2023) (0)
- Abstract 5722: The mutational signatures of 100,477 targeted sequenced tumors (2023) (0)
- Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
- [Combined chemotherapy of paclitaxel and cisplatin in the treatment of relapsed small-cell lung cancer]. (2007) (0)
- Additional file 4: Table S3. of Nighttime eating and breast cancer among Chinese women in Hong Kong (2017) (0)
- OP-JNCI200057 329..337 (2021) (0)
- Clinical findings in chordoma families with and without T gene duplications and chordoma patients reported to the Surveillance, Epidemiology and End Results Program (2021) (0)
- Abstract 146: DNA methylation age of paired tumor-normal breast tissue in Chinese women with breast cancer (2020) (0)
- Abstract 2553: Characterization of rare germline variants in somatically mutated melanoma genes in melanoma-prone families. (2013) (0)
- Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma (2014) (0)
- SUITOR: Selecting the number of mutational signatures through cross-validation (2020) (0)
- Rare copy number variants (CNVs) and breast cancer risk (2021) (0)
- Nighttime eating and breast cancer among Chinese women in Hong Kong (2017) (0)
- Abstract LB-336: Association of variant rs2046210 at 6q25.1 (ESR1) with breast cancer risk suggests heterogeneity by E-cadherin tumor tissue expression (2012) (0)
- Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors (2017) (0)
- Editorial: Chordoma: advances in biology and clinical management (2023) (0)
- Abstract P3-01-26: Mammographic density in relation to breast cancer risk factors among Chinese women (2022) (0)
- DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer (2023) (0)
This paper list is powered by the following services:
Other Resources About Xiaohong Rose Yang
What Schools Are Affiliated With Xiaohong Rose Yang?
Xiaohong Rose Yang is affiliated with the following schools:
